Literature DB >> 16763870

[Pseudoxanthoma elasticum].

M S Ladewig1, C Götting, C Szliska, P C Issa, H-M Helb, I Bedenicki, H P N Scholl, F G Holz.   

Abstract

Pseudoxanthoma elasticum (PXE) is an inherited disorder that is associated with accumulation of mineralized and fragmented elastic fibers in the skin, vessel walls, and Bruch's membrane. Clinically, patients exhibit characteristic lesions of the skin (soft, ivory-colored papules in a reticular pattern that predominantly affect the neck), the posterior segment of the eye (peau d'orange, angioid streaks, choroidal neovascularizations), and the cardiovascular system (peripheral arterial occlusive disease, coronary occlusion, gastrointestinal bleeding). There is no causal therapy. Recent studies suggest that PXE is inherited almost exclusively as an autosomal recessive trait. Its prevalence has been estimated to be 1:25,000-100,000. The ABCC6 gene on chromosome 16p13.1 is associated with the disease. Mutations within the ABCC6 gene cause reduced or absent transmembraneous transport that leads to accumulation of substrate and calcification of elastic fibers. Although based on clinical features the diagnosis appears readily possible, variability in phenotypic expressions and the low prevalence may be responsible that the disease is underdiagnosed. This review covers current knowledge of PXE and presents therapeutic approaches.

Entities:  

Mesh:

Year:  2006        PMID: 16763870     DOI: 10.1007/s00347-006-1353-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  115 in total

1.  Mutations in ABCC6 cause pseudoxanthoma elasticum.

Authors:  A A Bergen; A S Plomp; E J Schuurman; S Terry; M Breuning; H Dauwerse; J Swart; M Kool; S van Soest; F Baas; J B ten Brink; P T de Jong
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Novel ABCC6 mutations in pseudoxanthoma elasticum.

Authors:  Nicolas Chassaing; Ludovic Martin; Juliette Mazereeuw; Laurence Barrié; Sonia Nizard; Jean-Louis Bonafé; Patrick Calvas; Alain Hovnanian
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

Review 3.  [Pseudoxanthoma elasticum--a visual diagnosis].

Authors:  L Fäh
Journal:  Schweiz Med Wochenschr       Date:  1991-05-04

4.  Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).

Authors:  Martin G Belinsky; Zhe-Sheng Chen; Irina Shchaveleva; Hao Zeng; Gary D Kruh
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

5.  Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.

Authors:  Andrew C Browning; A K K Chung; F Ghanchi; S P Harding; M Musadiq; S J Talks; Y C Yang; W M Amoaku
Journal:  Ophthalmology       Date:  2005-07       Impact factor: 12.079

6.  Dark adaptation and scotopic perimetry over 'peau d'orange' in pseudoxanthoma elasticum.

Authors:  F G Holz; C Jubb; F W Fitzke; A C Bird; F M Pope
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

7.  Unusual traumatic retinal haemorrhages associated with angioid streaks.

Authors:  M J Britten
Journal:  Br J Ophthalmol       Date:  1966-09       Impact factor: 4.638

Review 8.  Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment-genome interface?

Authors:  J Uitto; L Pulkkinen; F Ringpfeil
Journal:  Trends Mol Med       Date:  2001-01       Impact factor: 11.951

9.  Exclusion of an elastin gene (ELN) mutation as the cause of pseudoxanthoma elasticum (PXE) in one family.

Authors:  M C Raybould; A J Birley; C Moss; M Hultén; C M McKeown
Journal:  Clin Genet       Date:  1994-01       Impact factor: 4.438

10.  Subcellular localization and N-glycosylation of human ABCC6, expressed in MDCKII cells.

Authors:  Emese Sinkó; Attila Iliás; Olga Ujhelly; László Homolya; George L Scheffer; Arthur A B Bergen; Balázs Sarkadi; András Váradi
Journal:  Biochem Biophys Res Commun       Date:  2003-08-22       Impact factor: 3.575

View more
  7 in total

Review 1.  [Clinical applications of OCT angiography].

Authors:  P P Fang; M Lindner; J S Steinberg; P L Müller; M Gliem; P Charbel Issa; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

2.  [Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks].

Authors:  A Lommatzsch; G Spital; M Trieschmann; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

3.  Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients.

Authors:  Ulf Diekmann; Ralf Zarbock; Doris Hendig; Christiane Szliska; Knut Kleesiek; Christian Götting
Journal:  J Mol Med (Berl)       Date:  2009-07-03       Impact factor: 4.599

4.  [Hereditary metabolic diseases with cutaneous manifestations : An update].

Authors:  J Frank; P Poblete-Gutiérrez
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 5.  [Pseudodominant inheritance of pseudoxanthoma elasticum].

Authors:  P Charbel Issa; M Gliem; F G Holz; C Knabbe; D Hendig
Journal:  Ophthalmologe       Date:  2015-08       Impact factor: 1.059

6.  Non-vascular vision loss in pseudoxanthoma elasticum.

Authors:  Irena Tsui; Brian S Fuchs; Chai Lin Chou; Stanley Chang; Stephen H Tsang
Journal:  Doc Ophthalmol       Date:  2007-11-22       Impact factor: 2.379

7.  [Intraocular injections of bevacizumab in rare indications--two cases].

Authors:  T Wecke; C Knop; W Schreiber; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.